Cargando…
Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy
Cell-free circulating DNA (cfDNA) in plasma has gained global interest as a diagnostic material for noninvasive prenatal testing and cancer diagnosis, or the so-called “liquid biopsy”. Recent studies have discovered a great number of valuable genetic and epigenetic biomarkers for cfDNA-based liquid...
Autores principales: | Gai, Wanxia, Sun, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356936/ https://www.ncbi.nlm.nih.gov/pubmed/30634483 http://dx.doi.org/10.3390/genes10010032 |
Ejemplares similares
-
Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests
por: Kubiliute, Raimonda, et al.
Publicado: (2021) -
Cell-Free DNA Fragmentomics in Liquid Biopsy
por: Ding, Spencer C., et al.
Publicado: (2022) -
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
por: Palanca-Ballester, Cora, et al.
Publicado: (2021) -
Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020) -
Cell-free DNA-based liquid biopsies in neurology
por: Gaitsch, Hallie, et al.
Publicado: (2022)